maltofer 50 mg/ml tipat, liuos
vifor france - iron(iii)-hydroxide polymaltose complex - tipat, liuos - 50 mg/ml - rautaoksidipolymaltoosikompleksit
maltofer 100 mg purutabletti
vifor france - iron(iii)-hydroxide polymaltose complex - purutabletti - 100 mg - rautaoksidipolymaltoosikompleksit
maltofer 100 mg purutabletti
orifarm oy - iron(iii)-hydroxide polymaltose complex - purutabletti - 100 mg - rautaoksidipolymaltoosikompleksit
maltofer 50 mg/ml tipat, liuos
orifarm oy - iron(iii)-hydroxide polymaltose complex - tipat, liuos - 50 mg/ml - rautaoksidipolymaltoosikompleksit
maltofer 100 mg purutabletti
paranova oy - iron(iii)-hydroxide polymaltose complex - purutabletti - 100 mg - rautaoksidipolymaltoosikompleksit
maltofer 50 mg/ml tipat, liuos
paranova oy - iron(iii)-hydroxide polymaltose complex - tipat, liuos - 50 mg/ml - rautaoksidipolymaltoosikompleksit
emgesan 250 mg tabletti
viatris oy - magnesium hydroxide - tabletti - 250 mg - magnesiumhydroksidi
velphoro
vifor fresenius medical care renal pharma france - sucroferric oxyhydroxide - hyperphosphatemia; renal dialysis - lääkkeitä hoitoon hyperkalemia ja hyperphosphatemia - velphoro on tarkoitettu fosforin seerumin aikuisten krooninen munuaisten saannissa (ckd) ohjausobjektiin hemodialyysiin (hd) tai vatsakalvodialyysia (pd). velphoro is indicated for the control of serum phosphorus levels in paediatric patients 2 years of age and older with ckd stages 4-5 (defined by a glomerular filtration rate.
magnesiamaito 82.5 mg/ml oraalisuspensio
orion corporation - magnesium hydroxide pasta - oraalisuspensio - 82.5 mg/ml - magnesiumhydroksidi
gaviscon oraalisuspensio
nordic drugs ab - aluminium hydroxide gel, calcium carbonate, sodium alginate, sodium hydrogen carbonate - oraalisuspensio - algiinihappo